Venous thromboembolism in multiple myeloma - choice of prophylaxis, role of direct oral anticoagulants and special considerations
出版年份 2018 全文链接
标题
Venous thromboembolism in multiple myeloma - choice of prophylaxis, role of direct oral anticoagulants and special considerations
作者
关键词
-
出版物
BRITISH JOURNAL OF HAEMATOLOGY
Volume 183, Issue 4, Pages 538-556
出版商
Wiley
发表日期
2018-11-19
DOI
10.1111/bjh.15684
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Simvastatin reverses multiple myeloma serum-induced prothrombotic phenotype in endothelial cells via ERK 1/2 signalling pathway
- (2018) Rujiao Dong et al. BLOOD COAGULATION & FIBRINOLYSIS
- Safety and efficacy of apixaban for routine thromboprophylaxis in myeloma patients treated with thalidomide- and lenalidomide-containing regimens
- (2018) Neill P. F. Storrar et al. BRITISH JOURNAL OF HAEMATOLOGY
- Is anticoagulating haemodialysis patients with non-valvular atrial fibrillation too risky?
- (2018) Kathrine Parker et al. BRITISH JOURNAL OF HAEMATOLOGY
- Pharmacological properties of betrixaban
- (2018) Menno V Huisman et al. EUROPEAN HEART JOURNAL SUPPLEMENTS
- Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)
- (2018) Annie M. Young et al. JOURNAL OF CLINICAL ONCOLOGY
- Prediction of venous thromboembolism (VTE) in multiple myeloma (MM): Myeloma clot score (MCS).
- (2018) Kristen Marie Sanfilippo et al. JOURNAL OF CLINICAL ONCOLOGY
- Association of venous thromboembolism with increased mortality in patients with multiple myeloma.
- (2018) Martin W. Schoen et al. JOURNAL OF CLINICAL ONCOLOGY
- Warfarin use and the risk of mortality, stroke, and bleeding in hemodialysis patients with atrial fibrillation
- (2017) Brandon Kai et al. HEART RHYTHM
- Tissue Factor As a Predictor of Recurrent Venous Thromboembolism in Malignancy: Biomarker Analyses of the CATCH Trial
- (2017) Alok A. Khorana et al. JOURNAL OF CLINICAL ONCOLOGY
- Use of direct oral anticoagulants in patients on immunomodulatory agents
- (2017) L. Man et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism
- (2017) Jeffrey I. Weitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular and Thrombotic Complications of Novel Multiple Myeloma Therapies
- (2017) Weijuan Li et al. JAMA Oncology
- Warfarin utilisation and anticoagulation control in patients with atrial fibrillation and chronic kidney disease
- (2016) Felix Yang et al. HEART
- International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancer
- (2016) Dominique Farge et al. LANCET ONCOLOGY
- Management of recurrent venous thromboembolism in cancer patients
- (2016) Erica Romualdi et al. THROMBOSIS RESEARCH
- Cost-effectiveness analysis of low-molecular-weight heparin versus aspirin thromboprophylaxis in patients newly diagnosed with multiple myeloma
- (2016) Emilie Chalayer et al. THROMBOSIS RESEARCH
- Does the choice of thrombotic prophylactic drug depend on the known risk factors of patients with multiple myeloma in clinical practice?
- (2016) E. Chalayer et al. THROMBOSIS RESEARCH
- Thromboprophylaxis in multiple myeloma patients treated with lenalidomide – A systematic review
- (2016) Fatimah Al-Ani et al. THROMBOSIS RESEARCH
- A systematic review on the accumulation of prophylactic dosages of low-molecular-weight heparins (LMWHs) in patients with renal insufficiency
- (2015) Ferdows Atiq et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Risk factors for venous thromboembolism in immunoglobulin light chain amyloidosis
- (2015) K. M. Bever et al. HAEMATOLOGICA
- Effects of steroids on thrombogenic markers in patients undergoing unilateral total knee arthroplasty: A prospective, double-blind, randomized controlled trial
- (2015) Alexander S. McLawhorn et al. JOURNAL OF ORTHOPAEDIC RESEARCH
- Recurrent venous thromboembolism in anticoagulated patients with cancer: management and short-term prognosis
- (2015) S. Schulman et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Thromboelastography, thrombin generation test and thrombodynamics reveal hypercoagulability in patients with multiple myeloma
- (2015) Marina A. Gracheva et al. LEUKEMIA & LYMPHOMA
- SP559EFFECTIVENESS AND SAFETY OF WARFARIN USE FOR CARDIAC INDICATIONS IN HEMODIALYSIS PATIENTS
- (2015) Ahmad Chaaban et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma
- (2015) A. Keith Stewart et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk factors for venous thromboembolism in immunoglobulin light chain amyloidosis
- (2015) K. M. Bever et al. HAEMATOLOGICA
- The thromboprotective effect of bortezomib is dependent on the transcription factor Kruppel-like factor 2 (KLF2)
- (2014) L. Nayak et al. BLOOD
- Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials
- (2014) N. van Es et al. BLOOD
- “Real-world” data on the efficacy and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma who were treated according to the standard clinical practice: a study of the Greek Myeloma Study Group
- (2013) Eirini Katodritou et al. ANNALS OF HEMATOLOGY
- MELISSE, a large multicentric observational study to determine risk factors of venous thromboembolism in patients with multiple myeloma treated with immunomodulatory drugs
- (2013) Philippe Rodon et al. THROMBOSIS AND HAEMOSTASIS
- Use of Glucocorticoids and Risk of Venous Thromboembolism
- (2013) Sigrun A. Johannesdottir et al. JAMA Internal Medicine
- Recurrent venous thromboembolism while on anticoagulant therapy
- (2012) Jecko Thachil BLOOD REVIEWS
- Apixaban for Extended Treatment of Venous Thromboembolism
- (2012) Giancarlo Agnelli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Proteinuria and hypoalbuminemia are risk factors for thromboembolic events in patients with idiopathic membranous nephropathy: an observational study
- (2012) Sanjeev Kumar et al. BMC Nephrology
- Aspirin or enoxaparin thromboprophylaxis for patients with newly diagnosed multiple myeloma treated with lenalidomide
- (2011) A. Larocca et al. BLOOD
- Guidelines for supportive care in multiple myeloma 2011
- (2011) John A. Snowden et al. BRITISH JOURNAL OF HAEMATOLOGY
- Low Venous Thromboembolic Risk With Bortezomib in Multiple Myeloma and Potential Protective Effect With Thalidomide/Lenalidomide-based Therapy: Review of Data From Phase 3 Trials and Studies of Novel Combination Regimens
- (2011) Maurizio Zangari et al. Clinical Lymphoma Myeloma & Leukemia
- Aspirin, Warfarin, or Enoxaparin Thromboprophylaxis in Patients With Multiple Myeloma Treated With Thalidomide: A Phase III, Open-Label, Randomized Trial
- (2011) Antonio Palumbo et al. JOURNAL OF CLINICAL ONCOLOGY
- Warfarin Dosing in Patients With Impaired Kidney Function
- (2010) Nita A. Limdi et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study
- (2010) S. Y. Kristinsson et al. BLOOD
- Venous Thromboembolism After Spinal Cord Injury
- (2009) Robert W. Teasell et al. ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION
- Proteasome Inhibitors Enhance Endothelial Thrombomodulin Expression via Induction of Krüppel-Like Transcription Factors
- (2009) Toyoko Hiroi et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Safety and efficacy of single-agent lenalidomide in patients with relapsed and refractory multiple myeloma
- (2009) P. Richardson et al. BLOOD
- Pathogenesis and management of bleeding and thrombosis in plasma cell dyscrasias
- (2009) Charles Eby BRITISH JOURNAL OF HAEMATOLOGY
- Pomalidomide (CC4047) Plus Low-Dose Dexamethasone As Therapy for Relapsed Multiple Myeloma
- (2009) Martha Q. Lacy et al. JOURNAL OF CLINICAL ONCOLOGY
- Venous Thromboembolism in the Hematologic Malignancies
- (2009) Anna Falanga et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of high-dose dexamethasone on endothelial haemostatic gene expression and neutrophil adhesion
- (2009) Mohammad Amin Kerachian et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Dose escalation of low molecular weight heparin to manage recurrent venous thromboembolic events despite systemic anticoagulation in cancer patients
- (2009) M. CARRIER et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial
- (2009) S Vincent Rajkumar et al. LANCET ONCOLOGY
- Predicting recurrences or major bleeding in women with cancer and venous thromboembolism. Findings from the RIETE Registry
- (2009) Javier Trujillo-Santos et al. THROMBOSIS RESEARCH
- Acquired Dysfibrinogenemia Secondary to Multiple Myeloma
- (2008) Roman Kotlín et al. ACTA HAEMATOLOGICA
- High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS)
- (2008) C. Ay et al. BLOOD
- Deep vein thrombosis after monoclonal gammopathy of undetermined significance and multiple myeloma
- (2008) S. Y. Kristinsson et al. BLOOD
- Characterisation of haematological profiles and low risk of thromboembolic events with bortezomib in patients with relapsed multiple myeloma
- (2008) Sagar Lonial et al. BRITISH JOURNAL OF HAEMATOLOGY
- Thromboembolic events with lenalidomide-based therapy for multiple myeloma
- (2008) Smitha Patiyil Menon et al. CANCER
- Hemostatic effects of bortezomib treatment in patients with relapsed or refractory multiple myeloma
- (2008) M. Zangari et al. HAEMATOLOGICA
- Bortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple Myeloma
- (2008) Jesús F. San Miguel et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started